Drug and Medical Litigation Conference 2021- Presented by American Conference Institute (ACI)

Dechert is proud to sponsor ACI's Drug and Medical Device Litigation Conference 2021, taking place December 7 - 8 at the New York Marriott Marquis.

ACI’s Drug and Medical Device Litigation conference brings together an exceptional in-house presence on the faculty, the top defense firms representing pharmaceutical and medical device companies, experienced jurists from around the country, the FDA, and the DOJ. Designed for both networking and masters-level strategy sharing, this is the leading forum at which to learn winning life sciences products liability litigation strategies.

For more information please visit the conference website.

Dechert Sessions:

December 7, 2021 4:45 p.m.

Dechert panelist: Erik Snapp, Partner 

Daubert Revisited: Examining Recent Proposed Amendments to Rule 702 and What They Could Mean for the Future of Drug and Device Litigation

• Taking a look at what changes to the Daubert test may be coming down the pike
• What are the specifics of the possible new rule changes being considered by the Federal Rules Committee?
• What is the current status of these amendments? Where are they in the process?
• What would this reform mean for future litigation?

December 7, 2021 5:30 p.m.

Dechert panelist: Paul Lafata, Partner

Lessons Learned from Recent Developments in This Year’s Opioid Trials

• A comprehensive overview of the latest developments in this year’s opioid trials going forward in California, West Virginia, Oklahoma, Ohio, Washington, and New York
• Examining notable verdicts, settlements, judicial rulings, and key takeaways from the various trials
• Assessing nuances and unique elements of the opioid MDL
• Examining new theories of tort liability being advanced and how these expansions of traditional confines of tort law may impact other areas of products liability litigation
• What are we learning from these trials that will be useful to practitioners going forward?